申请人:Pfizer Inc.
                            
                            
                                公开号:US20140128363A1
                            
                            
                                公开(公告)日:2014-05-08
                            
                            The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
                            本发明涉及一种新的羟
肟酸衍
生物类,其用作LpxC
抑制剂,更具体地用于治疗细菌感染。